Selective Oral Drugs in Immunology
Immunic, Inc. (Nasdaq: IMUX) is a clinical-stage biopharmaceutical company with a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases.
Looking for a job?
Then check out our recommendations and explore new job opportunities.
Lochhamer Schlag 21, 82166 Gräfelfing, Germany